DSDamayanti Rusli Sjarif

Damayanti Rusli Sjarif

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Damayanti Rusli Sjarif has a total of 69 co-authors. Here are the top co-authors by number of shared publications:

  • R Priambodo

    Human Genetic Research Center, Indonesian Medical Education and Research Institute (IMERI), Universitas Indonesia, Jakarta, Indonesia

    6 shared publications
  • Y Ariani

    Human Genetic Research Center, Indonesian Medical Education and Research Institute (IMERI), Universitas Indonesia, Jakarta, 10430, Indonesia

    6 shared publications
  • Y Pangestika

    Human Genetic Research Center, Indonesian Medical Education and Research Institute, Universitas Indonesia, Jakarta 10430, Indonesia

    5 shared publications
  • Anom Bowolaksono

    Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Indonesia, Depok, Indonesia

    4 shared publications
  • C N Hafifah

    Human Genetic Research Center, Indonesian Medical Education and Research Institute (IMERI), Universitas Indonesia, Jakarta, Indonesia

    4 shared publications
  • Klara Yuliarti

    Department of Child Health, Faculty of Medicine Universitas Indonesia/Dr Cipto Mangunkusumo Hospital Jakarta Indonesia

    3 shared publications

Latest Publications

  • Open Access

    Effectiveness of a Tiered Referral System and Early Nutritional Intervention to Prevent and Recover Stunting in Under‐Five Indonesian Children

    by Damayanti Rusli Sjarif, Klara Yuliarti, Lanny Christine Gultom, Cut Nurul Hafifah, I. Gusti Lanang Sidiartha, Meta Herdiana Hanindita, Neti Nurani, Aidah Juliaty, Ali Alhadar, Anik Puryatni, et al.

    Stunting remains a major global malnutrition problem in children. A protocol for stunting prevention and management in Indonesia is needed to achieve the WHO's stunting reduction target by 40% in 2025. This study aimed to evaluate the effectiveness of a tiered referral system across different healthcare levels and the importance of animal proteins and food for special medical purposes (FSMP) in preventing and managing stunting in Indonesia. This one‐group pre–post experimental study involved children under 5 years old from 14 regencies in Indonesia. All subjects initially received education about breastfeeding and animal proteins. Eligible subjects were then given daily animal protein (milk and/or egg) supplementation. Subjects with weight faltering, underweight, or wasting were referred and given nutritional intervention for 2 weeks. If treatments failed to normalize undernutrition, subjects were referred to regional hospitals. Those confirmed as stunted or with low birth weight were directly referred for treatment and FSMP as indicated. A total of 1841 subjects received egg and/or milk supplementation. In 6 months, animal protein supplementation prevented weight faltering in 1320/1841 subjects (71.7%; 95% CI 69.6%–73.8%). Red flags management successfully prevented stunting in 536/709 subjects (75.6%; 95% CI 72.4%–78.8%) in 2 weeks. FSMP prescription for catch‐up growth in regional hospitals led to stunting recovery in 166/381 subjects (43.6%; 95% CI 38.6%–48.5%) in ±14 weeks. A tiered referral system with well‐defined treatment guidelines is crucial to address stunting in Indonesia. Timely referral and FSMP prescription for catch‐up growth can effectively treat stunting. Animal proteins and education are keys to preventing stunting in children.


  • Open Access

    Molecular analysis in exons 1 and 2 of the tripeptidyl peptidase 1 (TPP1) gene on patients with neuronal ceroid lipofuscinosis type 2 (CLN2) in Indonesia

    by Selsa Evani, Haryo Seno Pangestu, Muhammad Rafi Arisandi, Nurul Muhammad Prakoso, Rizky Priambodo, Bobby Pambudi, Cut Nurul Hafifah, Yulia Ariani Aswin, Retno Lestari, Damayanti Rusli Sjarif

    Neuronal ceroid lipofuscinosis type 2 (CLN2 disease) is an inborn error of metabolism due to the lack of catalytically-active tripeptidyl-peptidase (TPP1) enzym

  • Open Access

    DNA quality from buccal swabs in neonates: comparison of different storage time

    by Klara Yuliarti, Muchtaruddin Mansyur, Ina Susianti Timan, Yulia Ariani, Ernawati, I Gusti Lanang Sidhiarta, Nadhifa Tazkia Ramadhani, Nurul Muhammad Prakoso, Damayanti Rusli Sjarif

    BACKGROUND Genomic medicine has great potential for diagnoses, disease prediction, and targeted treatment. Buccal swabs are a suitable non-invasive method for neonates to obtain DNA samples. Due to Indonesia's geographical conditions, samples require a prolonged time to reach the genetic laboratory. This study aimed to compare the DNA quality of buccal swabs in neonates between immediate and after-storage extraction. METHODS This study was part of a study about the profile of human milk oligosaccharide and FUT2 genotype in Indonesian mother-infant dyads consisting of 20 neonates. 1 swab stick for each participant was taken using a standardized buccal swabbing protocol and divided into 2 isovolume aliquots, which were grouped into the immediate (extraction was performed within 3 days after sampling) and storage groups (extraction was performed on the 14th day after storage in 4°C). DNA yield and purity A260/280 ratio were measured by spectrophotometry. The PCR amplification and Sanger sequencing were performed to validate the DNA isolate quality for downstream application. RESULTS The DNA yield for the immediate group was similar compared with the storage group (9.50 [4.89] versus 9.10 [5.05] µg), p = 0.659, as well as DNA purity A260/280 (1.58 [0.24] versus 1.56 [0.28]), p = 0.785. PCR and sequencing of FUT2 results also showed similar quality between both groups. CONCLUSIONS The similar DNA quality and sequencing results between immediate and storage extraction confirmed that buccal swabs could be stored for 2 weeks, allowing ample time for sample shipping from remote areas to the laboratory.


  • Open Access

    Novel Interactions of Myristic Acid and FADS3 Variants Predict Atopic Dermatitis among Indonesian Infants

    by Conny Tanjung, Carla P. Harris, Hans Demmelmair, Sarah Dwitya, Zakiudin Munasir, Herawati Sudoyo, Marie Standl, Damayanti Rusli Sjarif, Berthold Koletzko

    Fatty acids exert a range of different biological activities that could be relevant in the development of atopic dermatitis (AD). This study investigated the association of glycerophospholipid fatty acids (GPL-FA) with AD, and their interactions with single nucleotide polymorphisms (SNP) of the FADS1-3 gene cluster. Among 390 infants of the Indonesian ISADI study, GPL-FA were measured in umbilical plasma (P-0y) and in buccal cells at birth (B-0y), and again in buccal cells at AD onset or one year (B-1y). Prospective and cross-sectional associations with AD were assessed by logistic regression. Interactions of GPL-FA with 14 SNP were tested assuming an additive model. AD was diagnosed in 15.4% of participants. In B-1y, C18:2n-6 was inversely associated with AD; and positive associations were observed for C18:1n-9, C20:4n-6, C22:6n-3 and C20:4n-6/C18:2n-6. There were no prospective associations with AD, however, a significant interaction between the SNP rs174449 and B-0y C14:0 (myristic acid) was observed. This study indicates that Indonesian infants with AD have increased rates of endogenous long-chain polyunsaturated fatty acid production, as well as higher C18:1n-9 levels. GPL-FA measured at birth do not predict later AD incidence; however, genotype interactions reveal novel effects of myristic acid, which are modified by a FADS3 variant.


  • Open Access

    Erratum: Daily consumption of growing-up milk is associated with less stunting among Indonesian toddlers

    by Damayanti Rusli Sjarif, Klara Yuliarti, William Jayadi Iskandar

    [This corrects the article DOI: 10.13181/mji.v28i1.2607]


  • Open Access

    Identification of novel variation in introns three and four of the iduronate-2-sulfatase gene in patients with mucopolysaccharidosis type II

    by M F Purwanto, A R Widyaningrum, R Priambodo, Y Ariani, S Arianto, Y Pangestika, A Bowolaksono, D R Sjarif

    To identify and analyze mutations that occur in introns of the iduronate-2-sulfatase (IDS) gene of patients with mucopolysaccharidosis type II (MPS II) in Indonesia. DNA samples from 6 patients with MPS II and 49 normal individuals were analyzed with direct sequencing of introns three and four. A novel variant was found at the site c.419-132del in intron three and three variants were found at c.507 + 26G>A, c.507 + 29G>A, and c.507 + 63T>G in intron four of the IDS gene. These variations occur in the non-splicing site of the IDS gene in patients with MPS II and normal individuals and do not affect the structure of the IDS gene. Alterations which occur in one site of intron three and three sites of intron four are new variations of the IDS gene found in Indonesian patients. This finding suggests that the IDS gene may show variation in other sites that could be associated with MPS II. These mutations can enrich the single nucleotide polymorphism database for the IDS gene globally. Further genotype studies should be performed to obtain a full profile of the IDS gene in patients with MPS II in Indonesia.

  • Open Access

    A Novel mutation in iduronate-2-sulfatase gene Exon 6 of an Indonesian patient with Mucopolysaccharidosis type II

    by A N K Putri, R Priambodo, Y Ariani, Y Pangestika, C N Hafifah, A Bowolaksono, D R Sjarif

    Mucopolysaccharidosis type II (MPS II or Hunter syndrome) is a rare X-linked recessive disease caused mutation of the gene encoding the lysosomal enzyme iduronate-2-sulfatase (IDS). Deficient lysosomal degradation of the glycosaminoglycans dermatan sulfate and heparan sulfate by mutant IDS leads to their accumulation in multiple tissues, causing progressive tissue hypertrophy (e.g., hepatosplenomegaly and macroglossia), various deformities, and narrowing of the respiratory tract among other symptoms. Here, we searched from additional IDS mutations in Indonesian patients to provide information for establishing associations with disease traits. Exon-specific PCR amplification and sequencing of IDS gene exon 6 were conducted on DNA samples from MPS II patients and healthy controls at Cipto Mangunkusumo National Referral Hospital, Jakarta, Indonesia. A novel mutation in an Indonesian patient with MPS II was identified, a 14 bp insertion mutation (c.792_793insCCCCTGTGGCCTAC) in IDS gene exon 6 resulting in the amino acid changes p.Tyr264_X269insProLeuTrpPro and X269Thr. This novel mutation likely alters the structure and function of IDS. We are currently analyzing other IDS gene exons to identify additional mutations linked to IDS. Such studies will help clarify MPS II pathophysiology and may lead to novel treatment strategies.

  • Open Access

    Variations on exon 3 of 6-pyruvoyl-tetrahydropterin synthase gene in Indonesian population

    by L M Dewi, R Priambodo, Y Ariani, Y Pangestika, C N Hafifah, K Yuliarti, D R Sjarif

    Pyruvoyltetrahydropterin synthase (PTPS) is one of the several enzymes involved in tetrahydrobiopterin (BH4) biosynthesis. The deficiency of BH4 can cause hyperphnylalaninaemia (HPA). Mutations in PTS gene can alter protein function. We conducted genetic analysis of exon 3 of PTS gene of an Indonesian patient with PTPS-deficiency and healthy individuals. Direct sequencing of DNA samples was performed from an Indonesian patient with PTPS deficiency and 33 healthy individuals. No mutation was identified in the patient sample. However, a total of 6 novel variations were recorded in exon 3 of PTS. All these variations were found to be single-base alterations. The 6 novel variations identified in exon 3 of healthy individuals in this study were missense mutations. This variation data is expected to contribute to the development of the new database of Single Nucleotide Polymorphism (SNP) on PTS as well as to serve as a biomarker for the diagnosis of patients with PTPS deficiency.

  • Open Access

    Novel variations in Exon 4 of the iduronate 2-sulfatase gene in six Indonesian patients with mucopolysaccharidosis type II

    by M F Purwanto, R Priambodo, Y Ariani, Y Pangestika, C N Hafifah, A Bowolaksono, D R Sjarif

    Mucopolysaccharidosis type II (MPS II) is an X-linked lysosomal storage disorder caused by the inability to produce iduronate 2-sulfatase (IDS). We genotyped exon 4 of the IDS gene in Indonesian patients with MPS II. To detect IDS gene mutations, DNA samples from 6 patients with MPS II and 49 normal individuals were analyzed with direct sequencing of exon 4. One novel mutation (c.489G>A) was identified in four of six patients. Protein analysis of these mutations revealed no amino acid sequence changes (silent mutation). Another 20 variations were found in normal individuals, including missense, nonsense, and silent mutations. The discovery of this novel mutation provides new mutational data for MPS II, whereas the identified variations strengthen the single nucleotide polymorphism database for the IDS gene. These mutation and variation data should be useful for identifying biomarkers for diagnosing MPS II.